These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6337067)

  • 1. The peritoneal reaction to the translocated copper intrauterine device in women and female rats.
    Avni A; David MP; Pauzner D
    Fertil Steril; 1983 Feb; 39(2):193-6. PubMed ID: 6337067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic removal of translocated intrauterine contraceptives devices.
    McKenna PJ; Mylotte MJ
    Br J Obstet Gynaecol; 1982 Feb; 89(2):163-5. PubMed ID: 6461352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of intrauterine devices following uterine perforation.
    Adoni A; Ben Chetrit A
    Contraception; 1991 Jan; 43(1):77-81. PubMed ID: 1825971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of IUD migration into the peritoneal cavity].
    Sabbatino M; Oliaro A; Billia P; Giangreco B
    Minerva Ginecol; 1981 Dec; 33(12):1155-8. PubMed ID: 7038557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine perforation by a Copper 7 intrauterine contraceptive device with subsequent penetration of the appendix. Case report.
    McWhinney NA; Jarrett R
    Br J Obstet Gynaecol; 1983 Aug; 90(8):774-6. PubMed ID: 6349675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of translocated and incarcerated intrauterine contraceptive devices.
    Mittal S; Gupta I; Lata P; Mahajan U; Gupta AN
    Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):232-4. PubMed ID: 3468943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device).
    Larsson B; Frankman O; Hamberger L
    Fertil Steril; 1981 Dec; 36(6):734-6. PubMed ID: 7308517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic removal of translocated intrauterine contraceptive devices.
    Gupta I; Sawhney H; Mahajan U
    Aust N Z J Obstet Gynaecol; 1989 Aug; 29(3 Pt 2):352-5. PubMed ID: 2533496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforated intraperitoneal intrauterine contraceptive devices: diagnosis, management, and clinical outcomes.
    Kho KA; Chamsy DJ
    J Minim Invasive Gynecol; 2014; 21(4):596-601. PubMed ID: 24462588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation.
    Haimov-Kochman R; Doviner V; Amsalem H; Prus D; Adoni A; Lavy Y
    Hum Reprod; 2003 May; 18(5):990-3. PubMed ID: 12721174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the lost IUD.
    Otolorin EO
    Afr J Med Med Sci; 1985; 14(3-4):125-9. PubMed ID: 3004172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
    Elhag KM; Bahar AM; Mubarak AA
    J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some adverse effects of copper-IUD.
    Cullberg G; Larsson B
    Acta Obstet Gynecol Scand; 1979; 58(1):87-90. PubMed ID: 419962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible risks of a copper and an inert intrauterine device situated in the abdominal cavity: an experimental study in pigs and dogs.
    Larsson B; Aström G; Einarsson S; Rydén L; Granberg-Ohman I; Lindhe BA
    Fertil Steril; 1981 Aug; 36(2):229-31. PubMed ID: 7196347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine perforation by the intra-uterine device.
    Raman S; Sivanesaratnam V; Sinnathuray TA
    Med J Malaysia; 1981 Sep; 36(3):151-4. PubMed ID: 7199110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.